Document Detail


Drug resistance to topoisomerase II inhibitors.
MedLine Citation:
PMID:  9615864     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We describe in this review the mechanisms of resistance to topoisomerase II inhibitors that have been identified in cell lines rendered resistant to drugs. They concern especially both quantitative and qualitative alterations of topoisomerase II, leading to drug insensitivity of the cells. Expression and activity of topoisomerase II have also been studied in a number of tumor specimens originating from patients, but the role of topoisomerase II alterations in drug resistance in the clinical setting has not yet been firmly established. It would be worthwhile, however, to develop predictive assays for drug activity in human cancers, based upon the topoisomerase II status of tumor samples.
Authors:
J Robert; A K Larsen
Related Documents :
1677434 - New potent verapamil derivatives that reverse multidrug resistance in human renal carci...
2576974 - Modulation of drug resistance in a daunorubicin resistant subline with oligonucleoside ...
10933194 - Genetic modification of haematopoietic cells for combined resistance to podophyllotoxin...
9219504 - Multienzyme-mediated stable and transient multidrug resistance and collateral sensitivi...
2272534 - Defective csa-dependent granulopoiesis in patients with chronic drug-induced neutropenia.
23132334 - In vitro investigations into the roles of drug transporters and metabolizing enzymes in...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Biochimie     Volume:  80     ISSN:  0300-9084     ISO Abbreviation:  Biochimie     Publication Date:  1998 Mar 
Date Detail:
Created Date:  1998-08-07     Completed Date:  1998-08-07     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  1264604     Medline TA:  Biochimie     Country:  FRANCE    
Other Details:
Languages:  eng     Pagination:  247-54     Citation Subset:  IM    
Affiliation:
Institut Bergonié et Université Victor Segalen Bordeaux, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
DNA Topoisomerases, Type II / antagonists & inhibitors*
Drug Resistance, Multiple
Drug Resistance, Neoplasm*
Enzyme Inhibitors / pharmacology*
Humans
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; EC 5.99.1.3/DNA Topoisomerases, Type II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bis(2,6-dioxopiperazines), catalytic inhibitors of DNA topoisomerase II, as molecular probes, cardio...
Next Document:  Diversity of DNA topoisomerases I and inhibitors.